科里林通过向RAG1来抑制炎症,从而改善糖尿病骨质疏松症
Zhi-Rou Lin1, Hao Yin2, Teng-Fei Wan3
1Department of Metabolism and Endocrinology, The First Affiliated Hospital, Hengyang Medical School, University of South China, Hengyang, Hunan 421001, China; Department of Pharmacology Xiangya School of Pharmaceutical, Sciences Central South University Changsha, 410013, China.
概括
科里林通过促进骨形成和减少炎症,有效治疗糖尿病骨质疏松症. 这项研究确定了重组激活基因1 (RAG1) 作为科里林的关键标.
科学领域:
- 生物化学 生化学
- 药理学 药理学是指药理学的学科.
- 骨生物学 骨生物学 骨生物学
背景情况:
- 糖尿病骨质疏松症 (DOP) 是糖尿病的严重并发症,其特征是慢性炎症和骨质损失.
- 目前对DOP的治疗方法有限,需要探索新型治疗剂.
- 科里林是一种来自Psoralea corylifolia L.的黄类化合物,具有抗炎性质,但其在DOP中的有效性尚未被探索.
研究的目的:
- 在糖尿病骨质疏松症的小鼠模型中评估科里林的治疗潜力.
- 阐明林在DOP中的作用的基础分子机制.
主要方法:
- 在实验室中评估林对巨细胞炎症,骨质细胞分化和骨质细胞形成的影响.
- 使用微型CT,生物力学测试和组织学,在肌肉中评估林在链毒素诱导的糖尿病骨质疏松症小鼠模型中.
- 分子对接和表面等离子体共振以识别和验证科里林的直接分子标.
- 通过siRNA和AAV介导的基因敲除,以确认标在科里林治疗效果中的作用.
主要成果:
- 在实验室中,科里林增强了骨质细胞分化,并抑制了骨质细胞形成.
- 科里林治疗改善了糖尿病骨质疏松症小鼠的骨质量和微型结构,通过促进骨形成和抑制骨再吸收.
- 科里林缓解了与糖尿病骨质疏松症相关的局部和全身炎症.
- 重组激活基因1 (RAG1) 被确定为林的直接结合标,调解其对骨代谢和炎症的影响.
结论:
- 科里林在糖尿病骨质疏松症中显示出显著的治疗潜力.
- 在DOP的背景下,RAG1是林的直接分子标,在调节骨代谢和炎症方面发挥着至关重要的作用.
相关概念视频
TGF - β Signaling Pathway
10.4K
The TGF-β signaling pathway regulates cell growth, differentiation, adhesion, motility, and development. TGF-β ligands that induce TGF-β signaling are synthesized in their latent form. Several proteases or cell surface receptors such as integrins act upon the latent form, releasing the active ligand. There are three types of mammalian TGF-βs: (TGF-β1, TGF-β2, and TGF-β3) that bind as homodimers or heterodimers to TGF-β receptors. The TGF-β receptors...
10.4K
Osteoclasts in Bone Remodeling
3.8K
Osteoclasts are cells responsible for bone resorption and remodeling. They originate from hematopoietic progenitor cells present in the bone marrow. Numerous progenitor cells fuse to form multinucleated cells, each with 10-20 nuclei. A single osteoclast has a diameter of 150 to 200 µM. These cells have ruffled borders that break down the underlying bone tissue and release minerals such as calcium into the blood in bone resorption. Osteoclasts cling to bones with their ruffled edges during...
3.8K
Hormones Regulating Blood Glucose
6.3K
Insulin is released by beta cells of the pancreas when blood glucose levels are high. It facilitates glucose absorption and utilization in insulin-dependent cells with insulin receptors on their plasma membranes. Insulin promotes glucose uptake by increasing the number of glucose transport proteins in the cell membrane, allowing glucose to enter the cell. As a result, glucose utilization and ATP production are enhanced.
In addition to accelerating glucose uptake and utilization, insulin has...
In addition to accelerating glucose uptake and utilization, insulin has...
6.3K
Hormones and Bone Tissue
3.6K
The endocrine system produces and secretes hormones, which interact with the skeletal system. These hormones control bone growth, maintain bone once it is formed, and remodel it.
Hormones That Influence Osteoblasts and/or Maintain the Matrix
Several hormones are necessary for controlling bone growth and maintaining the bone matrix. The pituitary gland secretes growth hormone (GH), which, as its name implies, controls bone growth. This happens in several ways: first, it triggers chondrocyte...
Hormones That Influence Osteoblasts and/or Maintain the Matrix
Several hormones are necessary for controlling bone growth and maintaining the bone matrix. The pituitary gland secretes growth hormone (GH), which, as its name implies, controls bone growth. This happens in several ways: first, it triggers chondrocyte...
3.6K
Diabetes: Management and Pharmacotherapy
848
The therapy for diabetes aims to alleviate hyperglycemia-related symptoms, prevent acute metabolic decompensation, and reduce chronic end-organ complications. Glycemic control is evaluated through short-term (self-monitoring, continuous glucose monitoring) and long-term (A1c, fructosamine) metrics, enabling near real-time tracking of blood glucose levels and reflecting glycemic control over specific time frames.
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
848
Bone Disorders
5.0K
Aging and its effect on bone remodeling is the most common cause of bone disorders. In young and healthy people, bone deposition and resorption happen at an equal rate to maintain optimal bone health.
Bone deposition is also affected by the levels of sex hormones like estrogen and testosterone that promote osteoblast activity and bone matrix synthesis. When the level of these hormones decreases due to aging, it causes a reduction in bone deposition. As a result, bone resorption by osteoclasts...
Bone deposition is also affected by the levels of sex hormones like estrogen and testosterone that promote osteoblast activity and bone matrix synthesis. When the level of these hormones decreases due to aging, it causes a reduction in bone deposition. As a result, bone resorption by osteoclasts...
5.0K


